MS Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Morgan Stanley is not a strong buy at the moment for a beginner investor with a long-term strategy. The technical indicators show a bearish trend, options data reflects a slightly bearish sentiment, and recent Congress trading data shows cautious behavior with more sales than purchases. While the company's financial performance in Q4 2025 was strong, the lack of clear positive catalysts and mixed analyst ratings suggest holding off on purchasing the stock right now.
The MACD is negatively expanding (-0.803), RSI is neutral at 32.065, and moving averages are converging. The stock is trading near its key support level (S1: 162.157), indicating potential downside risk. The pre-market price is $162, down 0.34%, and the SP500 is also down 0.55%, reflecting broader market weakness.
Morgan Stanley's Q4 2025 financials showed strong growth: revenue up 11.10% YoY, net income up 19.25% YoY, EPS up 20.72% YoY, and gross margin slightly improved. Analysts have raised price targets recently, with some maintaining Outperform and Buy ratings.
Technical indicators are bearish, and Congress members have been selling the stock in recent months. The AI Stock Picker and SwingMax signals are absent, and news sentiment around AI's impact on enterprise software adds uncertainty. Analysts' ratings are mixed, with some downgrades and neutral stances.
In Q4 2025, Morgan Stanley reported revenue of $28.804 billion (+11.10% YoY), net income of $4.25 billion (+19.25% YoY), EPS of $2.68 (+20.72% YoY), and a gross margin of 58 (+0.33% YoY). This reflects strong financial growth and operational efficiency.
Analyst ratings are mixed. Some firms raised price targets significantly (e.g., BofA to $220, Barclays to $219), while others downgraded the stock (e.g., Erste Group to Hold). The consensus outlook is constructive but cautious, with a focus on Morgan Stanley's diversified business model and strong Wealth Management division performance.
